Peptide Library/Hormones & HRT/Nandrolone Decanoate

Nandrolone Decanoate

FDA ApprovedExtensive Research

Also known as: Deca-Durabolin · Nandrolone · Deca · 19-Nortestosterone · Nandrolone Phenylpropionate · NPP

A 19-nortestosterone derivative used therapeutically for joint health, collagen synthesis, and lean tissue preservation — one of the most studied anabolic compounds in clinical medicine.

Overview

Nandrolone Decanoate (Deca-Durabolin) is a 19-nortestosterone derivative and one of the most well-studied anabolic-androgenic steroids in clinical medicine. It was FDA-approved in the 1960s for the treatment of anemia associated with chronic kidney disease, and has been extensively studied for muscle wasting conditions, osteoporosis, and HIV-associated cachexia. In the longevity and wellness space, nandrolone is valued primarily for its unique collagen-stimulating and joint-protective properties. Unlike testosterone, nandrolone significantly increases collagen synthesis (up to 50% in some studies), making it particularly beneficial for individuals with joint pain, connective tissue issues, or recovering from injuries. It also has a favorable anabolic-to-androgenic ratio (125:37 compared to testosterone's 100:100), meaning it builds tissue effectively with relatively lower androgenic side effects like hair loss and prostate enlargement. Nandrolone converts to dihydronandrolone (DHN) via 5-alpha reductase rather than DHT, which is actually less androgenic than nandrolone itself — the opposite of testosterone's conversion pattern.

However, it is strongly suppressive of natural testosterone production and must be used alongside TRT.

Mechanism of Action

Binds to androgen receptors with high affinity, promoting nitrogen retention, protein synthesis, and collagen production. Converts to DHN (a weaker androgen) via 5-alpha reductase rather than DHT. Stimulates erythropoietin production in kidneys. Increases bone mineral density through direct osteoblast stimulation. Enhances collagen synthesis in tendons, ligaments, and joints through progesterone receptor-mediated pathways.

Key Benefits

Significantly increases collagen synthesis and joint health
Promotes lean tissue preservation and growth
Improves bone mineral density
Lower androgenic side effects than testosterone (less hair loss, less prostate impact)
Enhances red blood cell production
Supports recovery from injuries and surgeries
Well-studied safety profile over decades of clinical use

Potential Side Effects

Suppression of natural testosterone (must use with TRT)
Potential progesterone-related side effects (water retention, gynecomastia)
Possible mood effects ('Deca depression' in some individuals)
Elevated prolactin in some users
Cardiovascular lipid changes (lowers HDL)
Liver stress minimal at therapeutic doses
Prolonged detection time in drug testing

Common Stacks

This peptide is commonly combined with the following compounds for synergistic effects:

Testosterone (required base)BPC-157TB-500GHK-CuHCG

Scientific References

Quick Reference

Typical Dose

Therapeutic/wellness: 50-100mg every 1-2 weeks. Performance: 200-400mg/week

Frequency

Once weekly to once every two weeks (decanoate ester)

Route

Intramuscular injection

Half-Life

6-12 days (decanoate ester); 2.7 days (phenylpropionate ester)

Cycle Length

12-16 weeks minimum due to long ester; often used continuously at low therapeutic doses

FDA Status

FDA approved (for anemia of chronic kidney disease)

Need to calculate dosing?

Use our reconstitution calculator to determine exact syringe measurements.

Open Calculator

This information is for educational purposes only. Consult a qualified healthcare professional before using any peptide. Dosing information reflects commonly reported protocols and may not be appropriate for everyone.

Related Peptides in Hormones & HRT